Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes.
Nursing home residents are at risk for acquiring and transmitting MDROs. A serial point-prevalence study of 605 residents in 3 facilities using random sampling found MDRO colonization in 45% of residents: methicillin-resistant Staphylococcus aureus (MRSA, 26%); extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL, 17%); vancomycin-resistant Enterococcus spp. (VRE, 16%); carbapenem-resistant Enterobacteriaceae (CRE, 1%). MDRO colonization was associated with history of MDRO, care needs, incontinence, and catheters. Infect Control Hosp Epidemiol 2016;1485-1488.
1Infectious Disease Clinical OutcomesResearch Unit (ID-CORE),Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California.
James A
JA
McKinnell
1Infectious Disease Clinical OutcomesResearch Unit (ID-CORE),Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California.
Loren G
LG
Miller
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Raveena
R
Singh
4Department of Biostatistics and Epidemiology,University of Massachusetts Amherst School of Public Health and Health Sciences,Amherst, Massachusetts.
Ken
K
Kleinman
5Department of Pathology and Laboratory Medicine,University of California,Irvine School of Medicine,Irvine,California.
Ellena M
EM
Peterson
5Department of Pathology and Laboratory Medicine,University of California,Irvine School of Medicine,Irvine,California.
Kaye D
KD
Evans
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Tabitha D
TD
Dutciuc
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Lauren
L
Heim
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Adrijana
A
Gombosev
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Marlene
M
Estevez
1Infectious Disease Clinical OutcomesResearch Unit (ID-CORE),Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California.
Bryn
B
Launer
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Tom
T
Tjoa
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Steven
S
Tam
1Infectious Disease Clinical OutcomesResearch Unit (ID-CORE),Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California.
Michael A
MA
Bolaris
3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California.
Susan S
SS
Huang
D002140:California / Q000453:epidemiology; D000073182:Carbapenem-Resistant Enterobacteriaceae / Q000302:isolation & purification; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D004755:Enterobacteriaceae / Q000302:isolation & purification*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology*; D006801:Humans; D016014:Linear Models; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D009735:Nursing Homes; D015995:Prevalence; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000453:epidemiology*; D065507:Vancomycin-Resistant Enterococci / Q000302:isolation & purification; D001618:beta-Lactamases / Q000302:isolation & purification
D001618:beta-Lactamases